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Background: Genomic microarrays have been used as the first-tier cytogenetic diagnostic test for patients with
developmental delay/intellectual disability, autism spectrum disorders and/or multiple congenital anomalies. The
use of SNP arrays has revealed regions of homozygosity in the genome which can lead to identification of
uniparental disomy and parental consanguinity in addition to copy number variations. Consanguinity is associated
with an increased risk of birth defects and autosomal recessive disorders. However, the frequency of parental
consanguinity in children with developmental disabilities is unknown, and consanguineous couples may not be
identified during doctor’s visit or genetic counseling without microarray.
Results: We studied 607 proband pediatric patients referred for developmental disorders using a 4 × 180 K array
containing both CGH and SNP probes. Using 720, 360, 180, and 90 Mb as the expected sizes of homozygosity for an
estimated coefficient of inbreeding (F) 1/4, 1/8, 1/16, 1/32, parental consanguinity was detected in 21cases (3.46%).
Conclusion: Parental consanguinity is not uncommon in children with developmental problems in our study
population, and can be identified by use of a combined CGH and SNP chromosome microarray. Identification of
parental consanguinity in such cases can be important for further diagnostic testing.
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Studies of the human genome using genomic arrays
(also called chromosomal microarrays) in the last
decade have revolutionized clinical cytogenetics and
changed the standard of care in medical genetics
[1-4]. The resolution of the studies has evolved from
the megabase level of the bacterial artificial chromo-
some (BAC) arrays during the early 2000s to the kilo-
base or exon level of the current oligonucleotide
arrays. The traditional microarrays were designed for
detection of gene copy number variations (CNVs) by
comparative genomic hybridization (CGH), and were
popularly called CGH arrays. The second type of ar-
rays containing a high density of probes for single* Correspondence: yfan@med.miami.edu
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reproduction in any medium, provided the ornucleotide polymorphisms (SNPs), so called SNP array,
reveals both CNVs and homozygosity in the genome.
The third type of genomic arrays uses a combination
of probes designed to detect CNVs and probes to geno-
type SNPs. The use of genomic microarrays has signifi-
cantly improved accuracy and diagnostic yield in
comparison with the conventional karyotype. Recently,
genomic microarrays have been used as the first-tier
cytogenetic diagnostic test for patients with develop-
mental delay/intellectual disability, autism spectrum
disorders and/or multiple congenital anomalies [2-4].
Many studies have shown the advantages of gen-
omic arrays in detecting pathogenic CNVs. Our la-
boratory has performed CGH array studies on about
2500 patients with developmental disorders since
2005, and reported a 14% detection rate for patho-
genic CNVs [5,6].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Fan et al. Molecular Cytogenetics 2013, 6:38 Page 2 of 6
http://www.molecularcytogenetics.org/content/6/1/38The use of SNP arrays has revealed regions of homo-
zygosity (ROH) in the genome which can lead to identi-
fication of uniparental disomy (UPD) and parental
consanguinity in addition to CNVs [7,8]. It is well
known that consanguinity is associated with an in-
creased risk of congenital anomalies and autosomal re-
cessive diseases [9-12]. The recently published Geneva
International Consanguinity Workshop report dis-
cussed the health impact of consanguinity and high-
lighted the importance of evidence-based counseling
recommendations for consanguineous marriage and for
undertaking genomic and social research in defining
the various influences and outcomes of consanguinity
[12]. However, the frequency of parental consanguinity
in children with developmental disabilities is unknown,
and consanguineous couples may not be identified dur-
ing doctor’s visit or genetic counseling without micro-
array study as our data have shown. Here we report our
study results on patients referred for developmental
problems using a combined CGH/SNP array with a
focus on detection of parental consanguinity.
Results
A total of 607 proband pediatric patients were tested
over a one year period, including 130 from Brazil and
477 from south Florida. Pathogenic CNVs were detected
in 97 cases (15.98%). SNP genotyping suggested presence
of UPD in three cases (0.49%), including two UPD20
and a UPD14. Our results suggested presence of parental
consanguinity in 21 cases (3.46%) including 4 (3.07%)
from Brazil and 17 (3.56%) referred from hospitals in
south Florida (Table 1).
ROHs larger than 5 Mb were observed in 86 cases
(data details not provided in this paper) including 21
with results suggesting presence of parental consan-
guinity. Among the 21 patients (Table 2), three had an
average of 686 Mb of ROH with an estimated coeffi-
cient of inbreeding (F) ¼ (Figure 1); five had an aver-
age 329 Mb of ROH with an estimated F 1/8; five had
an average of 196 Mb of ROH with an estimated F 1/16;
and eight had an average 91 Mb of ROH with an
estimated F 1/32. Post-testing information on parental
relationship was available in 14 of the 21 cases. A par-
ental relationship of 1st cousins was confirmed in all





No. of cases with pathogenic
CNV (%)
South FL 477 75 (15.72)
Brazil 130 22 (16.92)
Total 607 97 (15.98)cases with an estimated F 1/32 suggestive of a mating
type of half first cousins or first cousins once removed,
three were said having parents as 2nd cousins; One
couple was consanguineous but relationship was not
specified; In the remaining case, parents said they are
not related but from the same small city. In the three
cases with F1/8 suggestive of a 2nd degree relation-
ship, one was an uncle-niece mating; one said to be
first cousins; and the other was said to be distant rela-
tives. Among the two children with F1/4, one was a
product of a brother-sister mating, and the other’s
parents said they were not related.
Discussion
In addition to pathogenic CNVs and UPDs, approxi-
mately 3.5% of children with intellectual and/or devel-
opmental disabilities in our study populations showed
greater than 68 Mb of ROH, suggesting presence of
parental consanguinity. Post-testing surveys confirmed
the 1st cousin relationships for all the cases with an
estimated F 1/16 and presence of consanguinity in 4
out of 5 cases with an estimated F1/32 although the
information from medical records was incomplete or
inconsistent with the suggested mating type. In our
practice, we report results suggesting presence of par-
ental consanguinity but not specify the biological rela-
tionship of the parents as recommended by the
ACMG guidelines [13], because SNP array analysis is
not designed to be a paternity test or to assign a spe-
cific relationship between the parents of the proband
patient. Also, the observed size of ROH may not pre-
cisely predict the true biological relationship due to
variables such as recombination during meiosis, mul-
tiple loops of consanguinity or multiple generations of
breeding within a relatively closed community. For the
patients showing an estimated F ¼ or 1/8, we have in-
cluded the percentage of homozygosity in our clinical
report and stated that the result may suggest a first-
or second-degree parental relationship or incestuous
mating.
Incestuous parental relationships identified by SNP-
based microarrays have been reported previously. One
was a 3-year-old boy with multiple medical conditions
showing 668 Mb of genomic homozygosity which was
consistent with the patient being conceived as theNo. of cases with UPD (%) No. of cases with ROH ≥68 Mb (%)
3 (0.63) 17 (3.56)
0 4 (3.08)
3 (0.49) 21 (3.46)
Table 2 The cases with parental consanguinity
Case #* Age Sex Referring reasons Size of HZ (Mb) Estimated coefficient of inbreeding (F) Post-testing information on mating type
001 6 y F ID 598 1/4 Brother-sister
002 3 y M DD, DE, DF,RA 839 1/4 No related
003 18 y M DD, ID 624 1/4 NA
004 23 d F CA 345 1/8 Uncle-niece
005 7 y M DD 383 1/8 1st cousins
006 3 d M CA 285 1/8 NA
007 9 d M SZ 338 1/8 Distantly related
008 12 F DD, DF 292 1/8 NA
009 12 y F SKS, MD 187 1/16 1st cousins
010 9 y M SS 196 1/16 1st cousins
011 1 y M DD 250 1/16 1st cousins
012 7 y M DF, CA, RF 208 1/16 1st cousins
013 3 y M DD 139 1/16 NA
014 7 y F DD, DF, FT 114 1/32 2nd cousins
015 2 y F DD, FT 85 1/32 From the same small town
016 5 y M DD 120 1/32 Consanguineous
017 1 m F CA 69 1/32 2nd cousins
018 1 y F ID, GR, SS 88 1/32 NA
019 6 y F DD 86 1/32 2nd cousins
020 18 d M DF, MM 72 1/32 NA
021 3 y F DD 96 1/32 NA
Abbreviations: CA congenital anomalies, DD developmental delay/disorder, DE diaphragmatic eventration, DF dysmorphic features, FT failure to thrive, GR growth
retardation, ID intellectual disability, MD motor delay, MM multiple malformations, NA no information available, RA renal anomalies, RF renal failure, SKS scoliosis
and kyphoscoliosis, SS short stature, SZ seizures. *Numbers are used for this publication only, not the real numbers used for patient management.
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In a report on a SNP data, ROH of greater than 20% of
the genome were identified in two of 5000 samples an-
alyzed in a cytogenetics laboratory in Australia [8].
Our study has shown that a level of ROH greater than
20% correlates with an estimated coefficient of in-
breeding F1/4 which is suggestive of a first degree rela-
tionship such as parent–child or brother-sister mating,
as exemplified in case 001. However, an incestuous re-
lationship, which represents a complicated social and
legal issue, may not be readily identified during a doc-
tor’s visit or genetic counseling, as shown in our post-
testing survey. Genetic counseling for consanguinity
can be complicated particularly when incestuous mat-
ing is uncovered by use of microarrays.
The frequency of consanguineous mating may vary
significantly in different geographic regions or in dif-
ferent ethnic populations [12,15-17]. Our study pa-
tients were referred from hospitals in South Florida
(mainly Miami-Dade and Broward counties) and Brazil.
Hispanic or Latino Americans account for 65% of the
population in Miami-Dade and 25% of the populationin Broward (2010 census data). The Hispanic or Latino
Americans in Florida originate mainly from Cuba (32%)
and Puerto Rico (28%) and Mexico (9%). It was esti-
mated in 2008 that over one million of Brazilians live in
USA and about 300,000 of them live in Florida. First
cousin marriage is legal in Florida. The rate of consan-
guineous marriage in Miami-Dade and Broward coun-
ties is unknown but is likely to be higher than the
generally estimated average (<1%) in USA. The rate of
consanguineous mating in Brazil was estimated as
1.6% with a heterogeneous geographic distribution
and half of the consanguineous marriages have a coef-
ficient of inbreeding F 1/16 or higher [18]. There was
a consensus that consanguineous marriages are asso-
ciated with an increased risk of congenital mal-
formations and autosomal recessive disease [12]. The
estimated excess risks of morbidity and precocious
mortality for the children with F1/4, 1/8, 1/16 and
1/32 are about 40%, 20%, 10%, 5%, respectively [9,10].
A recent review suggests that the risk for congenital
heart disease is increased in consanguineous mar-
riages [19].
Figure 1 A combined CGH and SNP array on a 6-year old girl who was initially referred for mental problems showed 598 Mb of
homozygous autosomal genome (light green blocks). This finding led to uncover the patient being conceived as the product of a brother-
sister mating (first degree relatives with a coefficient of inbreeding ¼). After further studies, she had a tentative diagnosis of 2-ketoglutarate
dehydrogenase deficiency, a rare autosomal recessive disease.
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ilies with a history of consanguineous mating, we
detected parental consanguinity in about 3.5% of chil-
dren referred for developmental problems. Most of
these children were referred for congenital anomalies
or multiple malformations, developmental delay or in-
tellectual disability, dysmorphic features, failure to
thrive/growth retardation or short stature. The finding
of parental consanguinity in these cases is highly sug-
gestive of an underlying recessive cause. For example,
following the array study, case 012 was diagnosed with
Schimke immune-osseous dysplasia, an autosomal-
recessive pleiotropic disorder caused by loss of func-
tion mutations in SMARCAL1 leading to spondyl-
oepiphyseal dysplasia, renal dysfunction and T-cell
immunodeficiency [20,21]. A diagnosis of autosomal
recessive spinal muscular atrophy has been suspected
in case 009. In case 001, the 6 year-old girl initially re-
ferred for mental problems had a history of proximal
renal tubular acidosis (RTA) at 18 months of age, basal
ganglia and corneal calcifications secondary to RTA.
Further diagnostic work-up has revealed increased ex-
cretion of Krebs cycle intermediate and a tentative
diagnosis of 2-ketoglutarate dehydrogenase deficiency,
a very rare metabolic disorder [22-24]. Involvement of
multiple recessive mutant genes or a complex genetic
mechanism is possible in some patients, particularly inthe children as products of incestuous mating. Con-
sanguinity may not be noted in many cases without
microarray studies and identification of the biological
relationship of the parents in such cases is clinically
important for additional diagnostic testing. Further
studies of phenotype and possible correlating meta-
bolic deficiency, as well as sequencing of the ROH re-
gions would determine the genetic mechanisms of the
developmental problems in these children.
Methods
Patients
Patients, all pediatric but one, included in this report
were referred for developmental delay or intellectual
disability, autism spectrum disorders, and/or congeni-
tal anomalies from November 1, 2011 to March 5,
2013. Approximately 80% of the patient samples origi-
nated in the Genetics Clinic at the University Miami
and other hospitals in south Florida. However, many
of the patients were of Latin American or Caribbean
descent or referred from Latin American countries.
The remaining 20% of patient samples were received
from Brazil.
Microarray studies
A combined CGH and SNP array, Agilent SurePrint
G3 4 × 180 K (Agilent, Santa Clara, USA) has been
Table 3 Theoretic size of ROH for coefficient of inbreeding (F) expected from the total 2881 Mb autosomal genome
(GRCh37/hg19)




Theoretic proportion of identical
by decent (%)
Expected ROH size and
range (Mb)
Parent–child/brother-sister 1st 1/4 25 720 (540 ~ 1080)
Uncle-niece/aunt-nephew/double
half cousins
2nd 1/8 12.5 360 (270 ~ 539)
First cousins/half uncle-niece 3rd 1/16 6.25 180 (135 ~ 269)
Half first cousins/first cousins once
removed
4th 1/32 3.125 90 (68 ~ 134)
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The array contains 180,000 oligonucleotide probes, in-
cluding approximately 120,000 CGH probes and 60,000
SNP probes with a resolution of 5 ~ 10 Mb for ROH de-
tection. Array studies were performed using a protocol
recommended by Agilent. Briefly, DNA was prepared
from a blood sample and purified using the QIAamp
DNA Blood Midi Kit (Qiagen) or DNeasy Blood & Tissue
Kit (Qiagen) when a sample was less than 0.5 ml. DNA
was quantified, digested and then labeled with Cy5 (testing
DNA) and Cy3 (reference DNA) and hybridized to the
microarray at 65°C for 21 ~ 24 hours. The microarray was
washed and analyzed using an Agilent C microarray scan-
ner and CytoGenomics Edition 2.0.6.0 software.
Criteria for reporting
We used the same criteria for detection and interpret-
ation of CNVs as previously reported [5,6]. A size of
20 Mb of interstitial ROH or 10 Mb of telomeric ROH
was used as the threshold for UPD when ROH was ob-
served on a single chromosome [7,8]. For detection of
parental consanguinity, we calculated the theoretic size
of ROH for coefficient of inbreeding (F) 1/4, 1/8, 1/16,
and 1/32 respectively using the total 2,881 Mb of auto-
somal genome (GRCh37/hg19) and its variable range
using the middle line between theoretic average sizes
(Table 3). Based on this calculation, a result was
reported suggesting presence of parental consanguinity
when ROHs were observed on multiple chromosomes
with a total size ≥68 Mb which correlates with an esti-
mated F 1/32. However, we did not specify the esti-
mated coefficient of inbreeding and the likelihood of
biologic relationship of the parents in our laboratory
report. ROHs on multiple chromosomes with a total
size of 10 ~ 67 Mb or ROHs on a single chromosome
which do not meet the criteria for UPD were reported
as identical by decent (shared parental ancestry). We
reported the individual ROH with a size ≥5 Mb either
on a single chromosome or on multiple chromosomes
to clinicians (data not shown) because rarely an ROH
may contain recessive mutations responsible for the
clinical phenotype. We have reported and interpreted
ROH using above described criteria starting in late2011 and our practice appears to be consistent with
the ACMG standards and guidelines recently pub-
lished [13].
Retrospective survey on parental consanguinity
Referring clinicians were contacted to obtain informa-
tion on the parent’s family relationship of the children
for whom laboratory results suggested presence of
parental consanguinity. The clinician provided infor-
mation based on either the notes of clinical geneticists
or family history in medical records. In some cases,
we obtained information on patient diagnosis after
microarray study.
This report is a summary of clinical cases tested in a
CLIA certified and Florida State licensed clinical la-
boratory with patients identification removed. This is
not an experimental research using human material
and therefore no IRB approval is necessary.
Consent
Written informed consent was obtained from the pa-
tient’s guardian/parent/next of kin for the publication
of this report and any accompanying images.
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